Introduction
Transforming growth factor-b (TGFb) belongs to a family of cytokines that regulate multiple cellular processes, including cell growth, apoptosis and differentiation. Dysfunction of TGFb signaling has been implicated in various human disorders ranging from vascular disease to cancer (Massague et al., 2000; Miyazono et al., 2003; Wu and Hill, 2009 ). The effects of TGFb are mediated by two separate Ser/Thr kinase receptors. TGFb first binds to the type II receptor; the type I receptor is thereafter recruited to the receptor complex and is phosphorylated in the cytoplasmic domain by the type II receptor (Massague, 1998) . The activated type I receptor then phosphorylates and activates the receptor-activated Smads (Smad2 and Smad3) (Shi and Massague, 2003; Moustakas and Heldin, 2009 ). The activated Smads interact with Smad4 and translocate into the nucleus were they function as transcription factors together with co-activators and co-repressors (Feng and Derynck, 2005) . It has been shown that the co-repressor TGFb-induced factor 1 (TGIF1) recruits specific repressor complexes to Smad2 and that histone deacetylase activity is required for TGIF1-mediated repression of Smad2-dependent transcription (Wotton et al., 1999a (Wotton et al., , b, 2001 Faresse et al., 2008) .
Fbxw7 (also known as Fbw7, hCDC4, Ago and SEL-10) is the substrate-recognition component of a specific ubiquitin ligase complex (Welcker and Clurman, 2008) . Fbxw7 is a tumor suppressor (Welcker and Clurman, 2008) and targets cyclin E (Koepp et al., 2001; Strohmaier et al., 2001) , c-Myc (Welcker et al., 2004; Yada et al., 2004) , Notch (Tetzlaff et al., 2004; Tsunematsu et al., 2004) , c-Jun (Wei et al., 2005) and sterol regulatory element-binding protein 1 (SREBP1; Sundqvist et al., 2005) for degradation in a phosphorylation-dependent manner. Fbxw7 is located within a chromosomal region that is commonly deleted in cancers, and inactivating Fbxw7 mutations have been found in many cancer cell lines. Here, we show that Fbxw7 targets the transcriptional repressor TGIF1 for degradation following phosphorylation of two Thr residues. By inactivating TGIF1, Fbxw7 enhances TGFb-dependent transcription. Inactivation of Fbxw7 results in the accumulation of phosphorylated TGIF1 and attenuation of TGFb-dependent transcription, proliferation and migration. In addition, TGIF1 accumulates in cancer cell lines with inactivating Fbxw7 mutations and these cells show disturbances in TGFbdependent signaling. Thus, Fbxw7 could be an important regulator of TGFb signaling by targeting the transcriptional repressor TGIF1 for degradation.
Results and discussion

TGIF1 is degraded by Fbxw7
To identify novel targets for Fbxw7, we searched protein databases with variations of the conserved Fbxw7 degron. One of the proteins picked up in this screen was TGIF1, a transcriptional repressor involved in TGFb signaling. TGIF1 has a potential Fbxw7 degron between Thr235 and Thr239 ( Figure 1a) . Importantly, it has been suggested that both Thr235 and Thr239 are phosphorylated in vivo (Lo et al., 2001) . To test if TGIF1 was a substrate for Fbxw7, we transfected HEK293T cells with TGIF1 in the absence or presence of Fbxw7, either wild-type or an inactive mutant lacking the F-box domain (DF). The levels of TGIF1 were reduced in the presence of wild-type Fbxw7, whereas the inactive mutant of Fbxw7 had no effect (Figure 1b ). There are three isoforms of Fbxw7: a-, b-, and g-isoforms.
Both the a-and g-isoforms are localized in the nucleus, whereas the b-isoform is cytoplasmic. To determine if the different isoforms of Fbxw7 have different specificity for TGIF1, we transfected HEK293T cells with TGIF1 either alone or in the presence of increasing amounts of the individual isoforms of Fbxw7. Fbxw7a and Fbxw7g greatly enhanced the degradation of TGIF1, whereas the b-isoform had a significantly lower effect on the turnover of TGIF1 (Figure 1c ). To determine if Fbxw7 could affect TGIF1-mediated regulation of transcription, we transfected HepG2 cells with a TGFb-regulated promoterreporter gene in the absence or presence of TGIF1 and Fbxw7, either wild-type or the DF mutant. The expression of the reporter gene was induced in response to TGFb treatment and TGIF1 repressed this induction (Figure 1d ). Importantly, expression of wild-type Fbxw7, but not the DF mutant, counteracted the TGIF1-dependent repression and restored TGFb-dependent expression of the reporter gene. To determine if Fbxw7 could affect TGIF1-mediated regulation of endogenous TGFb targets, we monitored the expression of plasminogen activator inhibitor-1 (PAI-1) in HepG2 cells transfected in the absence or presence of TGIF1 and Fbxw7. The expression of PAI-1 was induced in response to TGFb treatment and TGIF1 repressed this induction (Figure 1e ). Importantly, expression of Fbxw7 counteracted the TGIF1-dependent repression of PAI-1, suggesting that Fbxw7 is a negative regulator of TGIF1 function. In support of this hypothesis, expression of wild-type Fbxw7, but not the DF mutant, enhanced the expression of a TGFb-responsive promoter-reporter gene in cells treated with TGFb (Supplementary Figure S1 ).
Fbxw7 targets phosphorylated TGIF1 for degradation
To be recognized by Fbxw7, the substrate proteins need to be phosphorylated on specific Thr and/or Ser residues within their phosphodegrons. Mutation of Thr235, Thr239 or both residues to alanines enhanced the steady-state levels of TGIF1 when expressed in HEK293T cells (Figure 2a ), suggesting that both Thr235 and Thr239 are required for efficient degradation of TGIF1. This hypothesis was supported by our observation that mutation of Thr235 and Thr239, either individually or in combination, blocked Fbxw7-mediated degradation of TGIF1 (Figure 2b ). This notion was further supported by our observation that Fbxw7 enhanced the ubiquitination of wild-type TGIF1 but not the nonphosphorylated mutant form of the protein (Figure 2c ). These observations are in agreement with an earlier report suggesting that the phosphorylation of Thr235 and Thr239 could affect the stability of TGIF1 (Lo et al., 2001) . To determine if the potential phosphdegron in TGIF1 affected its transcriptional activity, we transfected HepG2 cells with a TGFbregulated promoter-reporter gene in the absence or presence of TGIF1, either wild-type or the T235A, T239A or T235A/T239A mutants, and Fbxw7. Wildtype TGIF1 repressed the expression of the reporter gene and Fbxw7 counteracted this TGIF1-dependent repression ( Figure 2d ). Mutation of Thr235 or Thr239 enhanced the repressor activity of TGIF1 and rendered the mutant proteins insensitive to Fbxw7, supporting the notion that Fbxw7 is a negative regulator of TGIF1 function by targeting TGIF1 for degradation. Endogenous TGIF1 interacted with endogenous Fbxw7 in HaCaT cells treated with the proteasome inhibitor MG132 (Figure 2e ). The interaction between TGIF1 and Fbxw7 was dependent on the integrity of Thr235 and Thr239 in TGIF1 (Figure 2f ), suggesting that the phosphorylation of these residues is important for the interaction between TGIF1 and Fbxw7. Taken together, our results show that phosphorylation of Thr235 and Thr239 creates a functional binding site for Fbxw7 in TGIF1, and that Fbxw7-dependent degradation of TGIF1 regulates TGFb-dependent transcription.
Endogenous Fbxw7 regulates endogenous TGIF1
To determine if endogenous Fbxw7 regulates the degradation of endogenous TGIF1, we used siRNA targeting the common region of Fbxw7. Endogenous TGIF1 accumulated in HepG2 cells transfected with Fbxw7 siRNA (Figure 3a) . TGIF1 migrates as a doublet in SDS-polyacrylamide gel electrophoresis (Figure 3a) . The upper band corresponds to hyperphosphorylated TGIF1, whereas the lower band corresponds to a hypophosphorylated form of the protein (Lo et al., 2001) . siRNA-mediated inactivation of Fbxw7 resulted in a dramatic increase in the hyperphosphorylated form of TGIF1 (Figure 3a) , suggesting that inactivation of Fbxw7 could result in the accumulation of TGIF1 molecules phosphorylated on Thr235 and/or Thr239.
To test this hypothesis, we generated a phosphorylationspecific anti-TGIF1 antibody directed against Thr235. This antibody recognized wild-type TGIF1 following expression in HEK293T cells, whereas it failed to recognize the T235A, T239A or T235A/T239A mutants (Supplementary Figure S2) . Using this antibody, we confirmed that the TGIF1 molecules accumulating in response to Fbxw7 inactivation are highly phosphorylated on Thr235 (Figure 3a) . To further understand the role of Fbxw7 in the degradation of TGIF1, we analyzed the expression of TGIF1 in wild-type and Fbw7-deficient HCT116 colon carcinoma cells (Rajagopalan et al., 2004) . The steady-state levels of TGIF1 were increased in Fbxw7-deficient HCT116 cells when compared with the parental cells (Figure 3b ). The TGIF1 molecules accumulating in the Fbxw7-deficient HCT116 cells were highly phosphorylated on Thr235, suggesting that this form of the protein is degraded by Fbxw7 under normal conditions. Interestingly, expression of the TGFb target PAI-1 was reduced in the Fbxw7-deficient cells, suggesting that the accumulation of TGIF1 in these cells affects TGFb-dependent signaling.
To confirm that the increased levels of TGIF1 resulted from decreased proteolysis, we measured the half-life of TGIF1 in Fbxw7-positive and -negative HCT116 cells. þ / þ and Fbxw7 À/À HCT116 cells were treated in the absence or presence of MG132 (10 mM) for 2 h. The expression of TGIF1 and a-tubulin was determined by western blotting. (e) HaCaT cells were transfected with the TGFb-responsive promoter-reporter genes PAI-1-Luc (left) or 12xCAGA-Luc (right) in the presence of either control or Fbxw7 siRNA. Where indicated, the cells were treated with TGFb for 12 h before the luciferase activity was measured as described in Figure 1d . The efficiency of the Fbxw7 siRNA was confirmed in parallel experiments by western blotting following immunoprecipitation of Fbxw7 (insets). (f) HepG2 cells were transfected with either control or Fbxw7 siRNA and treated with TGFb (1 ng/ml) for 2 h. The levels of PAI-1, Smad7, TGIF1, Fbxw7, Smad2, Smad3 and a-tubulin, and the phosphorylation of Smad2 were determined by western blotting (left). The asterisk (*) indicates the migration of a nonspecific band. HepG2 cells were transfected and treated as above. Total RNA was extracted with Trizol reagent (Invitrogen, Carlsbad, CA, USA). The RNA was subjected to RT with oligo-dT, followed by PCR with target-specific primers. The expression of the PAI-1, Smad7, Fbxw7 and TBP genes was determined by RT-PCR analysis (right).
TGIF1 was rapidly degraded in Fbxw7-positive cells, whereas the turnover of TGIF1 was delayed in Fbxw7-deficient HCT116 cells (Figure 3c ), suggesting that Fbxw7 dictates the degradation of TGIF1. This hypothesis was supported when HCT116 cells were treated with the proteasome inhibitor MG132. The levels of TGIF1 were enhanced in Fbxw7-positive cells in response to proteasome inhibition, whereas MG132 only had a limited effect on the levels of TGIF1 in Fbxw7-negative cells (Figure 3d) , suggesting that the high levels of TGIF1 in the Fbxw7-deficient cells are the result of inefficient degradation of phosphorylated TGIF1.
Interestingly, TGIF1 molecules with a mutation of Thr239 were not recognized by the phospho-Thr235 antibody (Supplementary Figure S2) . In addition, mutation of Thr239 blocked the interaction between TGIF1 and Fbxw7 (Figure 2d ), as well as Fbxw7-dependent degradation of TGIF1 (Figure 2b ). One explanation for these observations could be that the phosphorylation of Thr235 is dependent on the previous phosphorylation of Thr239. A similar scenario has been described for other Fbxw7 substrates. The degradation of nuclear SREBP1 is dependent on the phosphorylation of both Thr426 and Ser430 (corresponding to Thr235 and Thr239 in TGIF1, respectively) (Sundqvist et al., 2005) . The phosphorylation of Thr426 in SREBP1 is dependent on the initial phosphorylation of Ser430, which in turn is dependent on the phosphorylation of a third residue, Ser434 (Bengoechea-Alonso and Ericsson, 2009). Interestingly, the residue in TGIF1 corresponding to Ser434 in SREBP1 is a Ser residue, and it will be interesting to see if the phosphorylation and degradation of TGIF1 are controlled by a phosphorylation cascade similar to that described for SREBP1. The phosphodegrons of most Fbxw7 substrates are phosphorylated by GSK-3 and it will, therefore, be important to identify the kinase(s) involved in the phosphorylation of Thr235 and Thr239 in TGIF1. The phosphorylation-specific TGIF1 antibody described in this report could be an important tool in such studies.
To determine if endogenous Fbxw7 could regulate the repressor activity of TGIF1, we transfected HaCaT cells with two TGFb-regulated promoter-reporter genes in the presence of control or Fbxw7 siRNA. The expression of both reporter genes was enhanced in response to TGFb treatment in cells transfected with control siRNA (Figure 3e ). However, both reporter genes were nonresponsive to TGFb in cells transfected with the Fbxw7 siRNA, suggesting that endogenous Fbxw7 is a positive regulator of TGFb-dependent transcription as it targets the repressor TGIF1 for degradation. This hypothesis was supported when the expression of endogenous TGFb target genes was monitored in HepG2 cells transfected with Fbxw7 siRNA. In control cells, the expression of PAI-1 and Smad7 was enhanced in response to TGFb stimulation, whereas we were unable to detect any TGFb-dependent increase in the expression of these genes in Fbxw7-deficient cells (Figure 3f ). Similar effects were also observed in NIH/3T3 fibroblasts transfected with Fbxw7 siRNA (Supplementary Figure S3) . As indicated in Figure 3f Figure S4) . Importantly, the repression of PAI-1 in response to Fbxw7 inactivation was attenuated in cells transfected with TGIF1 siRNA (Supplementary Figure S4) , suggesting that TGIF1 is important for the repression of TGFb-dependent transcription in response to Fbxw7 inactivation. Taken together, these results show that endogenous Fbxw7 is a positive regulator of TGFbdependent transcription by targeting the repressor protein TGIF1, thereby promoting the expression of TGFb target genes.
Fbxw7 regulates TGFb signaling in cancer cells
Inactivating mutations in Fbxw7 have been found in a large number of tumors, including leukemias and cancers of the breast, bladder, liver, lung, ovary and bone (Welcker and Clurman, 2008) . To determine if TGIF1 accumulated in cancer cells with Fbxw7 mutations, we monitored the levels of TGIF1 in leukemia and breast cancer cell lines with either wild-type or mutant Fbxw7. Elevated levels of TGIF1 were found in both types of cells containing mutations in Fbxw7 (Figure 4a ). Again, it was mainly the hyperphosphorylated form of TGIF1 that accumulated in the mutant cell lines, suggesting that the degradation of this form of the protein is compromised in these cells. To determine if the accumulation of TGIF1 in these cells could affect TGFb-dependent signaling, we monitored the expression of PAI-1 protein in response to TGFb stimulation in Fbxw7-positive (MCF-7) and -negative (SUM149PT) breast cancer cells. PAI-1 protein was rapidly induced in response to TGFb in cells with wild-type Fbxw7, whereas the expression of PAI-1 was resistant to TGFb in Fbxw7 mutant cells (Figure 4b) .
TGFb signaling controls a large array of cellular processes, including cell proliferation and migration. In most cell types, TGFb signaling results in cell growth arrest. As illustrated in Figure 4c , TGFb stimulation resulted in cell growth arrest in Fbxw7-positive breast cancer cells, whereas the Fbxw7 mutant cells were resistant to the antiproliferative activity of TGFb. In fibroblasts, TGFb has a proliferative activity. To test if Fbxw7 could also regulate the proliferative activity of TGFb, we transfected NIH/3T3 fibroblasts with control and Fbxw7 siRNA and treated the cells with TGFb, followed by thymidine incorporation assays. As expected, TGFb treatment resulted in enhanced DNA synthesis in control cells, whereas the proliferation of the Fbxw7-negative fibroblasts was resistant to TGFb (Figure 4d ), suggesting that Fbxw7 controls TGFbregulated cell growth in a cell-type-specific manner.
To determine if Fbxw7-dependent degradation of TGIF1 could affect TGFb-dependent cell migration, we transfected NIH/3T3 cells with either control or Fbxw7 siRNA and used the transfected cells in woundhealing assays. As seen in Figure 4e , TGFb stimulation resulted in enhanced migration of control cells, whereas the migration of Fbxw7-deficient cells in response to TGFb was attenuated. Taken together, these results show that Fbxw7-dependent degradation of TGIF1 regulates a number of important TGFb-dependent processes, including transcription, proliferation and cell migration, and that these processes are disturbed in cancer cells harboring inactivating Fbxw7 mutations.
During early stages of carcinogenesis, TGFb, as well as members of the Smad family of transcription factors, will function as tumor suppressors based on their antiproliferatory effects (Massague et al., 2000) . However, during later stages of carcinogenesis, TGFb will enhance epithelial-mesenchymal transition and metastasis. We found that inactivation of Fbxw7 resulted in the accumulation of TGIF1 and attenuation of TGFbdependent transcription. In addition, inactivation of Fbxw7 regulated TGFb-dependent cell growth and migration in a cell-type-dependent manner. It will be important to determine if TGFb signaling is compromised in human cancers harboring Fbxw7 mutations and establish if this contributes to the tumor phenotype. It will also be important to determine if Fbxw7 affects TGFb-dependent processes in normal cells in vivo. The recently developed tissue-specific Fbxw7 knockout animals will be valuable tools in these studies (Onoyama and Nakayama, 2008) . However, TGIF1 does not only regulate TGFb-dependent signaling. TGIF1 has also been found to regulate the transcriptional activity of members of the RAR/RXR family of nuclear hormone receptors (Bartholin et al., 2006) . In addition, embryos from TGIF-deficient mice were found to be more sensitive to retinoic acid-induced teratogenesis. TGIF1 also interacts with c-Jun and this interaction has been shown to be important for the ability of TGIF1 to repress Smad-dependent transcription (Pessah et al., 2001) . Interestingly, c-Jun is also a target for Fbxw7-dependent degradation. It will be important to analyze the role of Fbxw7 in processes regulated by RAR/RXR and c-Jun.
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